Beijing ChaoYang Hospital
Beijing, Beijing Municipality, 100020, China
Location status: Recruiting
NCT Number: NCT04916197
Dexmedetomidine can attenuate the activity of the sympathetic nervous system under stress response and improve ischemia-reperfusion injury. The investigators hypothesized that the prolonged sedation of dexmedetomidine after successful reperfusion of endovascular thrombectomy may improve the clinical outcome of acute ischemic stroke patients.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Phase 4
Beijing, Beijing Municipality, 100020, China
Location status: Recruiting
Endovascular treatment with mechanical thrombectomy is the standard treatment for acute large vessel occlusion.
Dexmedetomidine is a commonly used sedative in endovascular thrombectomy of acute ischemic stroke.
Dexmedetomidine can attenuate the activity of the sympathetic nervous system under stress response and improve ischemia-reperfusion injury.
The investigators hypothesized that the prolonged sedation of dexmedetomidine after successful reperfusion of endovascular thrombectomy may improve the clinical outcome of acute ischemic stroke patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dexmedetomidine for 24h after patients finished endovascular thrombectomy and returned to ICU.
An equal dose of 0.9% saline 24h after patients finished endovascular thrombectomy and returned to ICU.
Time frame: 90 ± 14 days after thrombectomy
Modified Rankin Scale ≤ 2 points. mRS range from 0 to 6, higher scores mean a worse outcome.
Time frame: 24 ± 6 hours after thrombectomy
NIHSS (admission) - NIHSS (24h)
Time frame: on the 7-day or discharged day whichever comes first, up to 30 days
NIHSS (admission) - NIHSS (7day)
Time frame: on the 7-day or discharged day whichever comes first, up to 30 days
The difference of infarct volume between preoperative and 7-day or discharged day
Time frame: From the date of admission until discharged from ICU, up to 30 days
Length of ICU stay
Time frame: From the date of admission until discharged from hospital, up to 30 days
Length of hospital stay
Time frame: within 90-day after thrombectomy
hypotension (systolic blood pressure under 90mmHg), bradycardia (heart rate under 50bpm), hypoxemia (pulse oxygen saturation under 90%), and serious events such as death and life-threatening events
Time frame: within 90-day after thrombectomy
Death after thrombectomy within 90-day after operation
Contact information is provided by the study sponsor or research team.
Beijing Chao Yang Hospital
Other
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With Endovascular Thrombectomy on Long-term Prognosis in Patients With Acute Ischemic Stroke (PPDET)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07599904
Acute Ischemic Stroke, Brain Diseases
Flint, Michigan, United States
View Trial DetailsNCT07049692
Acute Ischemic Stroke, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07361302
Acute Ischemic Stroke, Brain Diseases
Buenos Aires, Argentina
View Trial DetailsNCT07347665
Acute Ischemic Stroke, Acute Ischemic Stroke (AIS) Related to a Distal Occlusion
Nishinomiya, Hyōgo, Japan
View Trial Details